About IMRB
The Mondor Institute for Biomedical Research (IMRB, U955 Inserm – Université Paris Est Créteil, UPEC) is one of the main biomedical research centres in the eastern part of the Paris region with national and international influence. The research teams develop high-level translational research in a wide variety of fields in direct connection with healthcare services […]
Read more about the IMRB
News
Rituximab-resistant memory B cells contribute to relapse in adult patients with immunological thrombocytopenia: A study led by Professor Matthieu Mahevas, Pirenne team at IMRB and published in Science Translational Medicine
Teams led by Prof. Matthieu Mahévas of the Reference Center for Autoimmune Cytopenias in Adults and the Mondor Institute of Biomedical Research (Henri-Mondor Hospital AP-HP/Inserm/University of Paris-Est Créteil), Prof. Jean-Claude Weill and Dr. Claude-Agnès Reynaud at the Institut Necker-Enfants Malades (Inserm/CNRS/University of Paris) studied the presence of self-reactive memory B lymphocytes before and after rituximab […]
Read moreSee all the news
Incoming seminars
Tissue damage induces a conserved stress response that initiates quiescent muscle stem cell activation :
«Philippos MOURIKIS - 13h – Videoconference Zoom»
When environmental sciences meet health sciences: 4th OSU-IMRB seminar (videoconference) :
«-»
Technical seminar on ISOPLEXIS technology :
«13h – Videoconference Teams or Zoom»
All incoming seminars
Departments
